REQUEST A DEMO
Total
USD $0.00
Search more companies

Turk Ilac Ve Serum A.S. (Turkiye)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Turk Ilac Ve Serum Sanayi Anonim Sirketi Profile Updated: April 27, 2023
Buy our report for this company USD 19.99 Most recent financial data: 2021 Available in: English Download a sample report

Turk Ilac Ve Serum A.S. is an enterprise in Turkiye, with the main office in Ankara. It operates in the Pharmaceutical Preparation Manufacturing industry. It currently has a total number of 519 (2023) employees. The latest financial highlights indicate a net sales revenue increase of 237.14% in 2021. Its total assets grew by 55.22% over the same period. Turk Ilac Ve Serum A.S.’s net profit margin decreased by 11.19% in 2021.

Headquarters
No:8 Bugduz Mahallesi Enver Pasa Caddesi Akyurt
Ankara; Central Anatolia; Postal Code: 06750

Contact Details: Purchase the Turk Ilac Ve Serum A.S. report to view the information.

Website: http://www.turkilac.com.tr

Basic Information
Total Employees:
Purchase the Turk Ilac Ve Serum A.S. report to view the information.
Outstanding Shares:
Purchase the Turk Ilac Ve Serum A.S. report to view the information.
Incorporation Date:
Key Executives
Purchase this report to view the information.
Chairman
Company Performance
Financial values in the chart are available after Turk Ilac Ve Serum A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TRY. Absolute financial data is included in the purchased report.
Net sales revenue
237.14%
Total operating revenue
237.14%
Operating profit (EBIT)
6.01%
Net Profit (Loss) for the Period
11.42%
Total assets
55.22%
Total equity
118.78%
Operating Profit Margin (ROS)
-24.68%
Net Profit Margin
-11.19%
Return on Equity (ROE)
-11.04%
Debt to Equity Ratio
-26.03%
Quick Ratio
0.48%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?